Fenwick's Julia Forbess Quoted on Climate Disclosure Requirements for Pharma and Biotech Companies
Corporate partner Julia Forbess was quoted in two articles by Biocentury. The first addressed the SEC's proposed climate disclosure rules and its impact on biotech companies, the second discussed how big pharma ESG reports can serve as guides for discerning and reporting environmental goals.
Read the full articles here and here (subscription required).